Hepatocellular carcinoma--epidemiological trends and risk factors.
about
Nutrition and Hepatocellular CancerThe impact of comorbidity on cancer and its treatmentMitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinomaPure laparoscopic hepatectomy for hepatocellular carcinoma with chronic liver diseaseTargeted therapy for hepatocellular carcinoma: novel agents on the horizonHepatocellular Cancer: New Kids on the BlockTargeting Hepatocellular Carcinoma: What did we Discover so Far?Prevention of Hepatocellular CarcinomaLiver Diseases and Long Non-Coding RNAs: New Insight and PerspectiveLaboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate modelOverexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancerNrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinomaP2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patientsThe global epidemiology of hepatocellular carcinoma: present and futureFunctional and topological properties in hepatocellular carcinoma transcriptome.AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma.Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liverEffect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.Effect of 5-aza-2'-deoxycytidine on immune-associated proteins in exosomes from hepatoma.Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material.Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis.Hepatitis B virus X stimulates redox signaling through activation of ataxia telangiectasia mutated kinaseFibrosis-dependent mechanisms of hepatocarcinogenesisPrognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.A multidisciplinary approach to the management of hepatocellular carcinoma.Dehydroabietic acid derivative QC2 induces oncosis in hepatocellular carcinoma cells.MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomesThe PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonismAssociation of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese han population: a case control study.Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients.Confirmation of drug delivery after liver chemoembolization: direct tissue doxorubicin measurement by UHPLC-MS-MS.HBx inhibits CYP2E1 gene expression via downregulating HNF4α in human hepatoma cells.MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.Study of ZHENG differentiation in hepatitis B-caused cirrhosis: a transcriptional profiling analysis.From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways.Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma.
P2860
Q26741102-DF798D42-6742-4149-8F61-CD53DE89FBA4Q26764935-9203960A-48E7-4161-960C-E7F3BC5FBFD7Q26850965-D79372EA-5622-4457-8922-C3A2A1AB0133Q26851431-B5B52EF3-269D-4774-84CF-2BC0730881DAQ27002288-2EA6B2A9-98ED-42AA-A1C7-8C264299EEAFQ27022642-681D848B-2640-4687-8A5E-CFB36C762332Q28077283-E867805A-6E86-4E80-99B8-66996CE5FBF2Q28079576-C2377A8B-96F2-4935-A6DF-C854546EA771Q28084106-277089AA-B783-4807-B7AE-AD4C544DB82FQ28382981-401A023F-A92E-44F9-9F99-4BFD53DFB7FDQ28383771-D2A8D915-14DA-43E7-A22F-2853BCA4CB74Q28383853-1C4DC90E-4CB9-47CC-B32D-ED98572F7B57Q28386398-C89B810B-5C14-40B4-ABA9-4622690E4F0AQ28654353-CC1CCB23-45EE-4D13-A4FD-8F75A27EA976Q31059884-F67A4FA3-03F9-446C-8E93-8281D9126626Q31158130-B44E3ADE-C983-4A49-AE73-52F39058AB74Q31170677-DF977A93-0270-4040-86D6-D0992731BCA5Q31170767-A11796BF-0EEF-4D1D-9B5B-846EB40E627FQ33580387-66FBF6EC-5C93-405A-B5A8-45D634A22C47Q33612207-EEE226DA-33E2-42E3-9047-00A9ACA92852Q33776248-8D94BC9E-6373-4A8E-9323-7CDD348256ACQ33802988-A04E35F7-BDCE-4A65-9366-E62FD66CA576Q33865082-869B6050-B556-4515-9392-E3D551AF7EB9Q33865883-AD02A8A9-D104-4D1F-B613-3031256B715BQ33914169-AC3679F8-C1C4-4546-B37F-272E46FC92AEQ33916361-477517B7-399E-4734-9CD4-BFDC9D1CBBAAQ33943367-B756E54D-A3DF-4D1A-AF83-8847FBDE383CQ33962495-20E3BD49-F5FD-42DC-A3F1-17F3321460BDQ33977054-1A8BDE80-4F9B-48A6-9285-C92A8F33FF46Q34075498-A00B72EF-7A91-47F3-9F08-D3745B3921FEQ34079481-B6987B9C-9D40-4388-BC7A-4202DF675012Q34116302-916135BB-2DFC-4937-AF99-2F49BBB63BACQ34131801-BFDBB2D7-3E79-478A-8122-290128BB2FF0Q34188474-0DB0B0E3-041B-4561-96B5-398BB5681C92Q34210319-0EF5F7DB-178A-4599-9C7A-C31451DFA1AEQ34215952-2EBFDA49-D2A4-488C-9874-C975C7C11477Q34297723-43826A79-9F14-4C40-A891-1E5E3652C30DQ34316989-E4A1CDA5-8463-49F7-9445-D84BC93449CAQ34389709-714199BF-BC57-4491-BC1B-42188970428DQ34510089-E48B1617-61AE-42D2-93B1-471672BD7484
P2860
Hepatocellular carcinoma--epidemiological trends and risk factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatocellular carcinoma--epidemiological trends and risk factors.
@en
Hepatocellular carcinoma--epidemiological trends and risk factors.
@nl
type
label
Hepatocellular carcinoma--epidemiological trends and risk factors.
@en
Hepatocellular carcinoma--epidemiological trends and risk factors.
@nl
prefLabel
Hepatocellular carcinoma--epidemiological trends and risk factors.
@en
Hepatocellular carcinoma--epidemiological trends and risk factors.
@nl
P356
P1433
P1476
Hepatocellular carcinoma--epidemiological trends and risk factors.
@en
P2093
Jan Bornschein
Kerstin Schütte
P356
10.1159/000218339
P577
2009-06-22T00:00:00Z